Literature DB >> 28471606

Upper Respiratory Tract Infection among Dialysis Patients.

Keren Cohen-Hagai1, Ilan Rozenberg1, Ze'ev Korzets1,2, Tali Zitman-Gal1, Yael Einbinder1,2, Sydney Benchetrit1,2.   

Abstract

BACKGROUND: Upper respiratory tract infection (URTI) occurs frequently in the general population and is considered a benign self-limited disease. Dialysis patients constitute a high risk population whose morbidity and mortality rate as a result of URTI is unknown.
OBJECTIVES: To assess the local incidence, morbidity and mortality of URTI in dialysis patients compared to the general population.
METHODS: In this retrospective cohort study we reviewed the charts of all chronic dialysis patients diagnosed with URTI at Meir Medical Center, Kfar Saba, Israel during the 2014-2015 winter season.
RESULTS: Among 185 dialysis patients, 40 were found to be eligible for the study. The average age was 66.1 ± 15.7 years, and the co-morbidity index was high. Influenza A was the most common pathogen found, followed by rhinovirus, respiratory syncytial virus and para-influenza. Of the 40 patients 21 (52.5%) developed complications: pneumonia in 20%, hospitalization in 47.5%, and respiratory failure requiring mechanical ventilation in 12.5%. Overall mortality was 10%. General population data during the same seasonal period showed a peak pneumonia incidence of 4.4% compared to 20% in the study population (P < 0.0001).
CONCLUSIONS: The study findings show that compared to the general population, URTI in dialysis patients is a much more severe disease and has a higher complication rate. Influenza A, the most common pathogen, is associated with a worse prognosis.

Entities:  

Mesh:

Year:  2016        PMID: 28471606

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  7 in total

Review 1.  SARS-CoV-2: Review of Conditions Associated With Severe Disease and Mortality.

Authors:  Joshua Eyitemi; Britanie Thomas; Yazmin Ramos; Xue Feng; Chiamaka Ezekwesili
Journal:  Int J Prev Med       Date:  2022-08-08

2.  Fine Particulate Air Pollution and Hospital Utilization for Upper Respiratory Tract Infections in Beijing, China.

Authors:  Daitao Zhang; Yaohua Tian; Yi Zhang; Yaying Cao; Quanyi Wang; Yonghua Hu
Journal:  Int J Environ Res Public Health       Date:  2019-02-13       Impact factor: 3.390

3.  Outcomes of coronavirus 2019 infection in patients with chronic kidney disease: a systematic review and meta-analysis.

Authors:  Yi-Chih Lin; Tai-Shuan Lai; Shuei-Liong Lin; Yung-Ming Chen; Tzong-Shinn Chu; Yu-Kang Tu
Journal:  Ther Adv Chronic Dis       Date:  2021-03-19       Impact factor: 5.091

4.  The Involvement of Chronic Kidney Disease and Acute Kidney Injury in Disease Severity and Mortality in Patients with COVID-19: A Meta-Analysis.

Authors:  Bin Wang; Qing Luo; Weiguang Zhang; Shuai Yu; Xiaowei Cheng; Lanlan Wang; Xiangmei Chen; Yizhi Chen
Journal:  Kidney Blood Press Res       Date:  2020-12-22       Impact factor: 2.687

5.  Comparison of 30-day case-fatality rate between dialysis and transplant Covid-19 patients: a propensity score matched cohort study.

Authors:  Tainá Veras de Sandes-Freitas; Luís Gustavo Modelli de Andrade; Jocemir Ronaldo Lugon; Ricardo Sesso; Lucio Roberto Requião Moura; Marina Pontello Cristelli; José Osmar Medina-Pestana
Journal:  J Nephrol       Date:  2021-10-22       Impact factor: 3.902

6.  The deacetylase sirtuin 6 protects against kidney fibrosis by epigenetically blocking β-catenin target gene expression.

Authors:  Juan Cai; Zhiwen Liu; Xian Huang; Shaoqun Shu; Xiaoru Hu; Meiling Zheng; Chengyuan Tang; Yu Liu; Guochun Chen; Lin Sun; Hong Liu; Fuyou Liu; Jinke Cheng; Zheng Dong
Journal:  Kidney Int       Date:  2019-09-17       Impact factor: 10.612

7.  Kidney disease is associated with in-hospital death of patients with COVID-19.

Authors:  Yichun Cheng; Ran Luo; Kun Wang; Meng Zhang; Zhixiang Wang; Lei Dong; Junhua Li; Ying Yao; Shuwang Ge; Gang Xu
Journal:  Kidney Int       Date:  2020-03-20       Impact factor: 10.612

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.